Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovarian cancer

C Westhoff1

  • 1Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Annual Review of Public Health
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Oral contraceptive use and increased pregnancies significantly reduce ovarian cancer risk. Surgical procedures like hysterectomy also offer protection, while family history and BRCA1 mutations increase risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Current and past depressive symptoms and contraceptive effectiveness level method selected among women seeking reproductive health services' Social Science and Medicine 2018214: 20-25.

Social science & medicine (1982)·2018
Same author

International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

ISBT science series·2017
Same author

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Vox sanguinis·2013
Same author

International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report.

Vox sanguinis·2011
Same author

International Society of Blood Transfusion Committee on terminology for red blood cell surface antigens: Macao report.

Vox sanguinis·2009
Same author

Alloanti-c in a c-positive, JAL-positive patient.

Vox sanguinis·2008

Area of Science:

  • Gynecologic Oncology
  • Epidemiology
  • Cancer Risk Factors

Background:

  • Ovarian cancer has high incidence and mortality, often presenting as disseminated disease.
  • Despite aggressive treatments, mortality rates remain high.
  • Decreased mortality in younger women is linked to oral contraceptive use.

Purpose of the Study:

  • To review established and potential risk factors for ovarian cancer.
  • To evaluate the impact of reproductive history and medical interventions on disease risk.

Main Methods:

  • Literature review of epidemiological studies on ovarian cancer risk factors.
  • Analysis of associations between oral contraceptive use, pregnancy, lactation, surgical history, family history, and genetic mutations with ovarian cancer risk.

Related Experiment Videos

Main Results:

  • Oral contraceptive use and increased number of pregnancies show a protective effect, with duration of use being key.
  • Lactation offers less protection than pregnancy; oral contraceptive use is less protective than pregnancy.
  • Hysterectomy and tubal ligation are protective, potentially by blocking carcinogen entry.
  • Family history and BRCA1 mutations significantly increase risk; other exposures lack consistent association.
  • Conflicting results exist for dietary galactose and infertility treatments' impact on risk.

Conclusions:

  • Reproductive factors like oral contraceptive use and parity are key protective elements against ovarian cancer.
  • Surgical interventions and genetic predisposition also play significant roles in disease risk.
  • Further research is needed to clarify the roles of diet and infertility treatments.